Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on NDI. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Discover how novel nintedanib synthesis routes with 92% yield and mild conditions reduce production costs by 30% while ensuring GMP compliance for IPF treatment.
Discover a metal-free, high-yield synthesis method for sulfonylated indolo[1,2-a]quinoline compounds. Reduce production costs and safety risks in pharmaceutical manufacturing.
Avoid heavy metal catalysts and anhydrous conditions in pyrido[1,2-a][1,3,5]-triazin-4-one synthesis. Reduce production costs and supply chain risks with this scalable, high-yield method.
Discover how Rh(III)-catalyzed tandem synthesis of 6-amino-5-acyl benzo[a]carbazole reduces production costs and improves yield for pharmaceutical intermediates.
Solve apixaban supply chain risks with this new synthesis route. Avoids toxic reagents, 88% yield, and 99.7% purity. Ideal for R&D and procurement.
Discover a cost-effective, high-yield synthesis of tolvaptan intermediate with no special equipment or toxic reagents. Reduce production risks and costs for your API manufacturing.
Discover how nickel-catalyzed carbonylation of ketone nitriles enables cost-efficient, high-yield production with broad functional group tolerance for pharmaceutical supply chains.
Discover a novel indolocyclopentane synthesis method with >95% yield and 93% ee. Ideal for pharmaceutical R&D targeting PC-3 prostate cancer cells. Scale up with CDMO expertise.
Discover a 3-step, high-yield synthesis of dimethylorphin phosphate with no chiral resolution. Reduce costs and scale efficiently for your antitussive drug supply chain.
Solve high-cost synthesis of alkylthiomethyl esters for APIs. Our CDMO expertise in iron-catalyzed routes delivers 81-93% yields, reducing energy costs and supply chain risks.
Discover a one-pot method for 2,3-dichloroquinoxaline derivatives with 90% yield, eliminating intermediate purification and reducing production costs by 30% for pharmaceutical intermediates.
Discover cost-effective, high-yield synthesis of tetrahydro-beta-carboline ketone using cobalt catalysis. Reduce supply chain risks with scalable, functional group-tolerant process.
Discover a cost-effective, high-yield synthesis method for alkyl nitrile substituted pyrrolo[1,2-a]quinoxaline. Eliminate expensive catalysts and harsh conditions. Ensure supply chain stability for your API production.
Solve low yield and environmental issues in bis(3-amino-4-hydroxyphenyl)hexafluoropropane production. Our CDMO expertise delivers high-purity, scalable synthesis for aerospace and pharmaceutical applications.
Discover how copper-catalyzed quinazolinone synthesis reduces costs, eliminates hazardous reagents, and achieves 94% yields for pharmaceutical intermediates. Scale-ready solution for R&D and procurement.
Discover a cost-effective buparvaquone synthesis method with 68% yield and 99.9% purity. Avoid silver nitrate, reduce wastewater, and ensure supply chain stability for bovine disease treatment.
Discover a metal-free, air-stable C2-phosphono indole synthesis method with >99% purity, high atom economy, and scalable production for pharmaceutical applications.
Solve supply chain risks with this novel 2-chlorothiophene-5-formic acid synthesis. 99.8% purity, 82% yield, and minimal waste. Ideal for rivaroxaban API production.
Discover how enaminone synthesis with mild conditions and high yields solves supply chain risks for pharma intermediates. Reduce costs and scale efficiently.
Solve supply chain risks with this glucose-based 1,2,4-triazole synthesis. No anhydrous conditions, high yield, scalable to 100MT. Contact for custom synthesis.